{"id":294789,"date":"2026-01-20T23:23:06","date_gmt":"2026-01-20T23:23:06","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/294789\/"},"modified":"2026-01-20T23:23:06","modified_gmt":"2026-01-20T23:23:06","slug":"google-backed-isomorphic-labs-delays-clinical-trial-timeline","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/294789\/","title":{"rendered":"Google-backed Isomorphic Labs delays clinical trial timeline"},"content":{"rendered":"

Jan 20 (Reuters) – Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical trials by the end of 2026, founder and CEO Demis Hassabis said on Tuesday.<\/p>\n

The comments, made at an event at the World Economic Forum in Davos, Switzerland, signal a delay in the Google-backed (GOOGL.O), opens new tab<\/a> startup’s ambitions.<\/p>\n

Sign up here.<\/a><\/p>\n

Hassabis had said last year the company would have AI-designed drugs in clinical trials by the end of 2025.<\/p>\n

Companies have been increasingly touting the real-world applications of AI, where the technology can be used to speed up research and development and shorten drug discovery timelines in the healthcare sector.<\/p>\n

Isomorphic was founded in 2021 as a spin-off from Alphabet’s AI research subsidiary, Google DeepMind, which is headed by Hassabis.<\/p>\n

One of DeepMind and Hassabis’ most celebrated breakthroughs was AlphaFold, an AI program that can predict protein structures.<\/p>\n

Isomorphic last year raised $600 million<\/a> in its first-ever external funding round led by Thrive Capital.<\/p>\n

Reporting by Jeffrey Dastin and Deborah Sophia; Editing by Shreya Biswas<\/p>\n

Our Standards: The Thomson Reuters Trust Principles., opens new tab<\/a><\/p>\n

Purchase Licensing Rights<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Jan 20 (Reuters) – Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first…\n","protected":false},"author":2,"featured_media":294790,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[261],"tags":[291,82519,82793,289,290,82758,82517,72110,82500,82559,87652,82531,87219,82529,142216,18,55396,82520,32356,82503,45748,87211,19,82766,82767,17,84435,721,93734,96155,96157,82524,82799,87647,2765,88229,83810,82510,87218,82558,82512,82800,82801,753,82,30150,107,82518],"class_list":{"0":"post-294789","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-artificial-intelligence","8":"tag-ai","9":"tag-amers","10":"tag-arti","11":"tag-artificial-intelligence","12":"tag-artificialintelligence","13":"tag-bisv","14":"tag-ceeu","15":"tag-ch","16":"tag-cmpny","17":"tag-destlita","18":"tag-destohlt","19":"tag-destousbsm","20":"tag-destoushem","21":"tag-destoustcm","22":"tag-drugen","23":"tag-eire","24":"tag-emea","25":"tag-europ","26":"tag-fin","27":"tag-fins","28":"tag-gen","29":"tag-heca","30":"tag-ie","31":"tag-invbis","32":"tag-invm","33":"tag-ireland","34":"tag-itse","35":"tag-legal","36":"tag-mlaisv","37":"tag-mrch","38":"tag-mrch1","39":"tag-namer","40":"tag-netsv","41":"tag-nrlpaohlt","42":"tag-phar","43":"tag-phmr","44":"tag-privt","45":"tag-publ","46":"tag-pve","47":"tag-reuters-legal","48":"tag-sci","49":"tag-srchen","50":"tag-swit","51":"tag-tech","52":"tag-technology","53":"tag-tmt","54":"tag-us","55":"tag-weu"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ie\/115930005714112087","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/294789","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=294789"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/294789\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/294790"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=294789"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=294789"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=294789"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}